| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| 17-Oxo Dexamethasone |
地塞米松-17-酮 |
1880-61-1 |
詳細(xì)
|
| Dapagliflozin C2 Epimer |
達(dá)格列凈雜質(zhì) |
2133407-75-5 |
詳細(xì)
|
| Ruxolitinib 2-(trimethylsilyl)ethoxy)methyl Impurity |
蘆可替尼雜質(zhì) |
941685-39-8 |
詳細(xì)
|
| Oxytocin A Trifluoroacetate |
|
17912-60-6 |
詳細(xì)
|
| Dimenhydrinate EP Impurity D DiHCl |
DIMENHYDRINATE EP IMPURITY D DIHCL |
2731709-33-2 |
詳細(xì)
|
| Algestone |
雙羥孕酮 |
595-77-7 |
詳細(xì)
|
| Algestone Acetonide |
丙縮阿爾孕酮 |
4968-09-6 |
詳細(xì)
|
| CisatracuriumBesylateEPImpurityHDibesylate |
苯磺順阿曲庫(kù)銨雜質(zhì)08 |
96946-44-0 |
詳細(xì)
|
| ChlortalidoneEPImpurityB |
氯噻酮相關(guān)物質(zhì)A |
5270-74-6 |
詳細(xì)
|
| ChlorpheniramineEPImpurityCMaleate |
氯苯那敏相關(guān)物質(zhì)C |
22630-25-7 |
詳細(xì)
|
| (S)-Ramosetron |
雷莫司瓊雜質(zhì) |
132036-90-9 |
詳細(xì)
|
| (S)-ClopidogrelPyridiniumBromideImpurity |
氯吡格雷溴化吡啶雜質(zhì) |
1396607-49-0 |
詳細(xì)
|
| CyproteroneAcetateEPImpurityC |
6-氯-1a-氯甲基-17-羥基孕甾-4,6-二烯-3,20-二酮醋酸酯 |
17183-98-1 |
詳細(xì)
|
| DaprodustatEthylEsterImpurity |
960540-96-9 |
960540-96-9 |
詳細(xì)
|
| DroxidopaImpurity3 |
2-氨基-3-(2H-1,3-苯并二氧雜環(huán)戊烯-5-基)-3-羥基丙酸 |
56672-56-1 |
詳細(xì)
|
| EdoxabanEthanediamideImpurity |
依度沙班雜質(zhì)F(單體) |
480452-37-7 |
詳細(xì)
|
| EdoxabanImpurity46 |
依度沙班雜質(zhì)49 |
480450-85-9 |
詳細(xì)
|
| FexofenadineEPImpurityG |
非索非那定EP雜質(zhì)G |
1187954-57-9 |
詳細(xì)
|
| Clindamycin phosphate EP Impurity L |
克林霉素磷酸酯EP雜質(zhì)L |
620181-05-7 |
詳細(xì)
|
| TranexamicAcidEPImpurityE |
(trans)-4-(((trans)-4-(aminomethyl)cyclohexanecarboxamido)methyl) cyclohexanecarboxylic |
82755-59-7 |
詳細(xì)
|
| TranexamicAcidEPImpurityF |
氨甲環(huán)酸雜質(zhì)F |
1599413-49-6 |
詳細(xì)
|
| IndapamideEPImpurityB |
脫氫吲達(dá)帕胺 |
63968-75-2 |
詳細(xì)
|
| N-FormylVortioxetine |
沃替西汀雜質(zhì)01 |
2135576-73-5 |
詳細(xì)
|
| CandesartanCilexetilEPImpurityA |
坎地沙坦乙酯 |
139481-58-6 |
詳細(xì)
|
| CandesartanCilexetilEPImpurityB |
坎地沙坦酯雜質(zhì)B |
869631-11-8 |
詳細(xì)
|
| CandesartanCilexetilEPImpurityC |
2-去乙氧基-2-羥基-1H-1-乙基坎地沙坦西來(lái)替昔酯 |
1185255-99-5 |
詳細(xì)
|
| CandesartanCilexetilEPImpurityD |
2-去乙氧基-2-羥基-2H-2-乙基坎地沙坦西來(lái)替昔酯 |
1185256-03-4 |
詳細(xì)
|
| CandesartanCilexetilEPImpurityE |
1H-1-乙基坎地沙坦西來(lái)替昔酯 |
914613-35-7 |
詳細(xì)
|
| CandesartanCilexetilEPImpurityF |
2H-2-乙基坎地沙坦西來(lái)替昔酯 |
914613-36-8 |
詳細(xì)
|
| BrexpiprazoleDi-N-Oxide |
依匹哌唑雜質(zhì)雜質(zhì)BPNO |
2247155-42-4 |
詳細(xì)
|
| BudesonideEPImpurityI |
布地奈德EP雜質(zhì)I |
113930-13-5 |
詳細(xì)
|
| CalcitriolEPImpurityC |
PRE-骨化三醇PTAD加合物 |
86307-44-0 |
詳細(xì)
|
| CarfilzomibImpurity(R,S,S,R,S) |
OPC-345512 |
2049025-45-6 |
詳細(xì)
|
| CarisoprodolEPImpurityA |
2-甲基-2-丙基-1,3-丙二醇異丙基氨基甲酸單酯 |
25462-17-3 |
詳細(xì)
|
| GoserelinEPImpurityKAcetate |
(Ser(Ac)4,D-Ser(tBu)6,Azagly10)-LHRH |
1926163-83-8 |
詳細(xì)
|
| ImatinibEPImpurityA |
(E)-3-(二甲基氨基)-1-(吡啶-3-基)丙-2-烯-1-酮 |
123367-26-0 |
詳細(xì)
|
| N-Methyl-N’-nitrosopiperazine |
1-甲基-4-亞硝基哌嗪 |
16339-07-4 |
詳細(xì)
|
| 4-Borono-L-phenylalanine |
4-硼-L-苯基丙氨酸 |
76410-58-7 |
詳細(xì)
|
| 2-Chloro-1-(p-tolyl)ethanone |
對(duì)甲基-2-氯乙酰苯 |
4209-24-9 |
詳細(xì)
|
| 2’-Epi-Lamivudine |
拉米夫定雜質(zhì)4 |
136846-20-3 |
詳細(xì)
|
| LansoprazoleThioxoImpurity |
蘭索拉唑硫醇雜質(zhì) |
1246819-06-6 |
詳細(xì)
|
| LinagliptinN-AcetylImpurity |
利格列汀N-乙酰雜質(zhì) |
1803079-49-3 |
詳細(xì)
|
| beta-Aspartyl-AsparticAcid |
門(mén)冬氨酸鳥(niǎo)氨酸雜質(zhì) |
60079-22-3 |
詳細(xì)
|
| LosartanEPImpurityC |
洛沙坦雜質(zhì)C |
114799-13-2 |
詳細(xì)
|
| N-BenzylVinylAnalogMedetomidine |
美托咪定標(biāo)準(zhǔn)品018 |
2250243-56-0 |
詳細(xì)
|
| (R)-Methotrexate |
D(-)-氨甲蝶呤 |
51865-79-3 |
詳細(xì)
|
| MometasoneEPImpurityR |
莫美他松EP雜質(zhì)R |
1370190-08-1 |
詳細(xì)
|
| OseltamivirEPImpurityFHCl |
(3R,4R,5S)-4-(乙酰氨基)-5-氨基-3-(1-甲基丙氧基)-1-環(huán)己烯-1-羧酸乙酯 |
1052063-37-2 |
詳細(xì)
|
| PaclitaxelSideChainImpurity |
(2R,3S)-3-(苯甲?；被?-2-羥基苯丙酸乙酯 |
153433-80-8 |
詳細(xì)
|
| 16α-HydroxyprednisoloneAcetate |
16alpha-羥基潑尼松龍醋酸酯 |
86401-80-1 |
詳細(xì)
|
| PioglitazoneEPImpurityB |
(5Z)-5-{4-[2-(5-乙基-2-吡啶基)乙氧基]亞芐基}-1,3-噻唑烷-2,4-二酮 |
136401-69-9 |
詳細(xì)
|
| RivaroxabanEPImpurityI |
利伐沙班雜質(zhì)J |
1151893-81-0 |
詳細(xì)
|
| TimololEPImpurityEMaleateSalt |
噻嗎咯爾雜質(zhì)E |
1026075-53-5 |
詳細(xì)
|
| TofacitinibImpurity7 |
托法替尼雜質(zhì) N |
1252883-90-1 |
詳細(xì)
|
| Pitavastatin Dihydrobenzophenanthridine Calcium Salt |
匹伐他汀雜質(zhì)1 |
1187966-91-1 |
詳細(xì)
|
| N-Benzhydryl-N,N',N'-trimethyl-ethylenediamine dihydrochloride |
|
1087694-87-8 |
詳細(xì)
|
| N-Benzhydryl-N,N',N'-trimethyl-ethylenediamine dihydrochloride |
|
878763-40-7 |
詳細(xì)
|
| Buspirone EP Impurity N |
丁螺環(huán)酮EP雜質(zhì)N |
257877-44-4 |
詳細(xì)
|
| D-Norepinephrine Bitartrate |
D-去甲腎上腺素酒石酸鹽 |
636-88-4 |
詳細(xì)
|
| Hydrocortisone EP Impurity M |
氫化可的松EP雜質(zhì)M |
566-35-8 |
詳細(xì)
|
| Bromopride |
溴滅吐靈 |
4093-35-0 |
詳細(xì)
|
| Isoflupredone acetate |
氟潑尼龍醋酸酯 |
338-98-7 |
詳細(xì)
|
| Calcipotriol EP Impurity E |
(1ALPHA,3BETA,5Z,7E)-24-環(huán)丙基-9,10-開(kāi)環(huán)膽甾-5,7,10(19)-三烯-1,3,24-三醇 |
129831-99-8 |
詳細(xì)
|
| 1-Methoxy Empagliflozin |
甲基 1-C-[4-氯-3-[[4-[[(3S)-四氫-3-呋喃基]氧基]苯基]甲基]苯基]-ALPHA-D-吡喃葡萄糖苷 |
1279691-36-9 |
詳細(xì)
|
| Imatinib EP Impurity J |
伊馬替尼（哌啶）-N-氧化物 |
571186-91-9 |
詳細(xì)
|
| Budesonide EP Impurity B |
布地奈德EP雜質(zhì)B |
1040085-98-0 |
詳細(xì)
|
| Budesonide EP Impurity C |
布地奈德雜質(zhì)C |
1040085-99-1 |
詳細(xì)
|
| Budesonide EP Impurity G |
布地奈德雜質(zhì)G |
137174-25-5 |
詳細(xì)
|
| Bupropion USP RC F |
安非他酮雜質(zhì)F |
857233-13-7 |
詳細(xì)
|
| Alogliptin 6-Chloro N-Desmethyl Impurity |
2-((6-氯-2,4-二氧代-3,4-二氫-2H-嘧啶-1-基)甲基)苯腈 |
865758-95-8 |
詳細(xì)
|
| (S)-Alogliptin Benzoate |
苯甲酸阿格列汀雜質(zhì)D |
1638544-64-5 |
詳細(xì)
|
| 5-(4-Fluorophenyl)-2-isopropyl-N,4-diphenyl-1H-pyrrole-3- carboxamide |
5-(4-氟苯基)-2-異丙基-N,4-二苯基-1H-吡咯-3-甲酰胺 |
666714-64-3 |
詳細(xì)
|
| 4S-Des-3-chloropyridine Edoxaban |
依度沙班雜質(zhì) |
767625-11-6 |
詳細(xì)
|
| Rivaroxaban Aminomethyl Impurity |
4-[4-[(5S)-5-(氨甲基)-2-羰基-3-唑烷基]苯基]-3-嗎啡啉酮 |
446292-10-0 |
詳細(xì)
|
| m-Cresol-6-Sulfonic Acid Ammonium Salt |
聚甲酚磺醛雜質(zhì) |
79093-71-3 |
詳細(xì)
|
| Memantine USP RC E |
N-甲?；?3,5-二甲基金剛烷 |
351329-88-9 |
詳細(xì)
|
| Budesonide EP Impurity E |
布地奈德EP雜質(zhì)E |
131918-64-4 |
詳細(xì)
|
| Moxifloxacin EP Impurity E |
8-羥基莫西沙星 |
721970-36-1 |
詳細(xì)
|
| rac Dehydro-O-Desmethyl Venlafaxine |
去甲文拉法辛酐的雜質(zhì) |
1346600-38-1 |
詳細(xì)
|
| N-Nitrosodibenzylamine |
N-硝基聯(lián)芐基胺 |
5336-53-8 |
詳細(xì)
|
| 3-Methyl-1,2,4-triazolo[3,4-a]phthalazine |
3-甲基-[1,2,4]三唑并[3,4-a]酞嗪 |
20062-41-3 |
詳細(xì)
|
| 2-(4-Nitrosopiperazin-1-yl)pyrimidine |
丁螺環(huán)酮雜質(zhì) |
872826-80-7 |
詳細(xì)
|
| Fluoxetine EP Impurity B |
氟西汀EP雜質(zhì)B |
23580-89-4 |
詳細(xì)
|
| Doxycycline EP Impurity A |
鹽酸多西環(huán)素EP雜質(zhì)A |
3219-99-6 |
詳細(xì)
|
| Thiamine EP Impurity B Chloride HCl |
硫胺素EP雜質(zhì)B氯鹽酸鹽 |
49614-72-4 |
詳細(xì)
|
| Exodiene Lurasidone |
魯拉西酮雜質(zhì) |
3024924-65-7 |
詳細(xì)
|
| Latanoprost Lactone Diol |
拉坦前列腺素內(nèi)酯二醇 |
145667-75-0 |
詳細(xì)
|
| N-Nitroso Paroxetine |
N-亞硝基帕羅西汀 |
2361294-43-9 |
詳細(xì)
|
| Metoclopramide EP Impurity G |
甲氧氯普胺EP雜質(zhì)G |
171367-22-9 |
詳細(xì)
|
| Metoclopramide EP Impurity F |
甲氧氯普胺EP雜質(zhì)F |
38339-95-6 |
詳細(xì)
|
| Milrinone |
米力農(nóng) |
78415-72-2 |
詳細(xì)
|
| Beclomethasone Dipropionate EP Impurity H |
二丙酸倍氯米松EP雜質(zhì)H |
5534-18-9 |
詳細(xì)
|
| Alverine EP Impurity C |
阿爾維林EP雜質(zhì)C |
13125-62-7 |
詳細(xì)
|
| Cyclopentolate EP Impurity A |
鹽酸環(huán)噴托酯EP雜質(zhì)A |
25209-52-3 |
詳細(xì)
|
| Paclitaxel EP Impurity N |
紫杉醇EP雜質(zhì)N |
27548-93-2 |
詳細(xì)
|
| NiMesulide EP IMpurity F |
尼美舒利EP雜質(zhì)F |
|
詳細(xì)
|
| Pyridoxine Impurity/4,4'-(oxybis(methylene))bis(5-(hydroxymethyl)-2-methylpyridin-3-ol) |
維生素B6雜質(zhì) |
5196-20-3 |
詳細(xì)
|
| Carbetocin S-Oxide II |
卡貝縮宮素雜質(zhì) |
|
詳細(xì)
|
| Carfilzomib (R)-Enantiomer |
卡非佐米雜質(zhì) |
1541171-65-6 |
詳細(xì)
|
| Reduced eptifibatide |
|
|
詳細(xì)
|